Related Experiment Video
Updated: Jun 27, 2025
10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
10.5K
Delivery of Chlorambucil to the Brain Using Surface Modified Solid Lipid Nanoparticles
Swagata Patra1, Joykrishna Dey1, Somnath Kar2
1Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
ACS Applied Bio Materials
|May 3, 2024
Summary
Researchers developed novel solid lipid nanoparticles (SLNs) modified with GAHBA-derived lipids to overcome the blood-brain barrier (BBB). These nanoparticles successfully delivered the anticancer drug chlorambucil (CLB) to brain glioma, showing enhanced efficacy and brain uptake.
Area of Science:
- Neuroscience
- Nanotechnology
- Pharmacology
Background:
- Drug delivery to the central nervous system (CNS) is hindered by the blood-brain barrier (BBB).
- Innovative delivery systems are crucial for treating CNS diseases effectively.
- GABA and GAHBA exhibit similar binding affinities to the GABA receptor.
Purpose of the Study:
- To develop GAHBA-modified solid lipid nanoparticles (SLNs) capable of crossing the BBB.
- To investigate the potential of these SLNs for delivering chlorambucil (CLB) to brain tumors.
- To evaluate the efficacy and brain uptake of the developed drug delivery system.
Main Methods:
- Docking studies of GABA and GAHBA with the GABA receptor.
- Development and characterization of GAHBA-modified SLNs using techniques like DSC, DLS, UV-vis, and TEM.
- In vitro drug release, cytotoxicity assays, and flow cytometry on human glioma and prostate cancer cell lines.
- In vivo biodistribution, brain uptake studies in mice, and SPECT/CT imaging in rats using 99mTc-labeled SLNs.
Main Results:
- GAHBA-modified SLNs demonstrated successful BBB penetration and enhanced brain uptake.
- SLNs exhibited high encapsulation efficiency and good storage stability for CLB.
- GABBA-modified CLB-loaded SLNs showed higher efficacy in human glioma cells (U87MG).
- In vivo studies confirmed increased brain accumulation of the SLNs.
Conclusions:
- Surface-modified SLNs using GAHBA-derived lipids represent a promising strategy for brain drug delivery.
- This approach facilitates the targeted delivery of anticancer drugs like CLB to brain gliomas.
- The developed nanoparticles hold potential for improving the therapeutic outcomes in CNS diseases.
More Related Videos
Related Concept Videos
01:29Drug Delivery: Parenteral Route
504
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
504
01:18Drug Delivery: Enteral Route
428
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
428